Differentiating Galactosemia from other diseases
|
Galactosemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Differentiating Galactosemia from other diseases On the Web |
|
American Roentgen Ray Society Images of Differentiating Galactosemia from other diseases |
|
Differentiating Galactosemia from other diseases in the news |
|
Risk calculators and risk factors for Differentiating Galactosemia from other diseases |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dayana Davidis, M.D. [2]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Differentiating Galactosemia from other Diseases
Galactosemia needs to differentiated from other diseases like:
References
- ↑ Sakura N, Mizoguchi N, Ono H, Yamaoka H, Hamakawa M (2000). "Congenital biliary atresia detected as a result of galactosemia screening by the Beutler method". Clin Chim Acta. 298 (1–2): 175–9. doi:10.1016/s0009-8981(00)00220-5. PMID 10876013.
- ↑ Müller D, Santer R, Krawinkel M, Christiansen B, Schaub J (1997). "Fanconi-Bickel syndrome presenting in neonatal screening for galactosaemia". J Inherit Metab Dis. 20 (4): 607–8. doi:10.1023/a:1005375629820. PMID 9266402.
- ↑ Stuhrman G, Perez Juanazo SJ, Crivelly K, Smith J, Andersson H, Morava E (2017). "False-Positive Newborn Screen Using the Beutler Spot Assay for Galactosemia in Glucose-6-Phosphate Dehydrogenase Deficiency". JIMD Rep. 36: 1–5. doi:10.1007/8904_2016_34. PMC 5680284. PMID 28078493.
- ↑ 4.0 4.1 4.2 Karadag N, Zenciroglu A, Eminoglu FT, Dilli D, Karagol BS, Kundak A; et al. (2013). "Literature review and outcome of classic galactosemia diagnosed in the neonatal period". Clin Lab. 59 (9–10): 1139–46. doi:10.7754/clin.lab.2013.121235. PMID 24273939.
- ↑ Senemar S, Ganjekarimi A, Senemar S, Tarami B, Bazrgar M (2011). "The prevalence and clinical study of galactosemia disease in a pilot screening program of neonates, southern iran". Iran J Public Health. 40 (4): 99–104. PMC 3481732. PMID 23113108.
- ↑ 6.0 6.1 Bezerra JA, Wells RG, Mack CL, Karpen SJ, Hoofnagle JH, Doo E; et al. (2018). "Biliary Atresia: Clinical and Research Challenges for the Twenty-First Century". Hepatology. 68 (3): 1163–1173. doi:10.1002/hep.29905. PMC 6167205. PMID 29604222.
- ↑ 7.0 7.1 Feldman AG, Mack CL (2015). "Biliary Atresia: Clinical Lessons Learned". J Pediatr Gastroenterol Nutr. 61 (2): 167–75. doi:10.1097/MPG.0000000000000755. PMID 25658057.
| Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings |
|---|---|---|---|---|
| Galactosemia | Hepatomegaly, jaundice, vomiting, cataract, sepsis, psychomotor retardation [4] | Direct and indirect hyperbilirubinemia [4] | Measurement of GALT/GALK/Epimerase activity in erthrocytes [5] | Hemophagocytosis, purpura fulminans [4] |
| Biliary atresia | persistent jaundice, dark urine, clay-colored stools, hepatomegaly [6] | Elevated total and direct bilirubin, ALT, AST, GGT [7] | Atretic biliary tree on liver biopsy [6] | Ascites, splenomegaly [7] |
| Fanconi Bickel syndrome | Example | Example | Example | Example |
| Glucose-6-phosphate dehydrogenase deficiency | Example | Example | Example | Example |